BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36908030)

  • 1. The impact of diet and ethnicity on gut microbiota variation in irritable bowel syndrome: A multi-center study.
    Khoo XH; Chong CW; Talha AM; Philip K; Teh CS; Isa AM; Wong MS; Chew DC; Wong Z; Jusoh NS; Maksum NMM; Mokhtar NM; Majid HA; Ali RAR; Lee YY; Mahadeva S
    J Gastroenterol Hepatol; 2023 Aug; 38(8):1259-1268. PubMed ID: 36908030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome.
    Naseri K; Dabiri H; Rostami-Nejad M; Yadegar A; Houri H; Olfatifar M; Sadeghi A; Saadati S; Ciacci C; Iovino P; Zali MR
    BMC Gastroenterol; 2021 Jul; 21(1):292. PubMed ID: 34261437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
    Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol of the Bergen brain-gut-microbiota-axis study: A prospective case-report characterization and dietary intervention study to evaluate the effects of microbiota alterations on cognition and anatomical and functional brain connectivity in patients with irritable bowel syndrome.
    Berentsen B; Nagaraja BH; Teige EP; Lied GA; Lundervold AJ; Lundervold K; Steinsvik EK; Hillestad ER; Valeur J; Brønstad I; Gilja OH; Osnes B; Hatlebakk JG; Haász J; Labus J; Gupta A; Mayer EA; Benitez-Páez A; Sanz Y; Lundervold A; Hausken T
    Medicine (Baltimore); 2020 Sep; 99(37):e21950. PubMed ID: 32925728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
    Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
    Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet-microbiota interaction in irritable bowel syndrome: looking beyond the low-FODMAP approach.
    Dale HF; Lorentzen SCS; Mellin-Olsen T; Valeur J
    Scand J Gastroenterol; 2023; 58(12):1366-1377. PubMed ID: 37384386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.
    Valeur J; Småstuen MC; Knudsen T; Lied GA; Røseth AG
    Dig Dis Sci; 2018 Feb; 63(2):429-436. PubMed ID: 29302878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two microbiota subtypes identified in irritable bowel syndrome with distinct responses to the low FODMAP diet.
    Vervier K; Moss S; Kumar N; Adoum A; Barne M; Browne H; Kaser A; Kiely CJ; Neville BA; Powell N; Raine T; Stares MD; Zhu A; De La Revilla Negro J; Lawley TD; Parkes M
    Gut; 2022 Sep; 71(9):1821-1830. PubMed ID: 34810234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics.
    Staudacher HM; Scholz M; Lomer MC; Ralph FS; Irving PM; Lindsay JO; Fava F; Tuohy K; Whelan K
    Clin Nutr; 2021 Apr; 40(4):1861-1870. PubMed ID: 33183883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.
    Harvie RM; Chisholm AW; Bisanz JE; Burton JP; Herbison P; Schultz K; Schultz M
    World J Gastroenterol; 2017 Jul; 23(25):4632-4643. PubMed ID: 28740352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.
    Staudacher HM; Whelan K
    Proc Nutr Soc; 2016 Aug; 75(3):306-18. PubMed ID: 26908093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
    Bennet SMP; Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Öhman L; Simrén M
    Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Exclusion Diets on Symptom Severity and the Gut Microbiota in Patients With Irritable Bowel Syndrome.
    Lenhart A; Dong T; Joshi S; Jaffe N; Choo C; Liu C; Jacobs JP; Lagishetty V; Shih W; Labus JS; Gupta A; Tillisch K; Mayer EA; Chang L
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e465-e483. PubMed ID: 34022450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FODMAP meal challenge test: a novel investigation to predict response to low-FODMAP diet in non-constipating irritable bowel syndrome.
    Ghoshal UC; Mustafa U; Mukhopadhyay SK
    J Gastroenterol Hepatol; 2024 Feb; 39(2):297-304. PubMed ID: 38014751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis.
    So D; Loughman A; Staudacher HM
    Am J Clin Nutr; 2022 Oct; 116(4):943-952. PubMed ID: 35728042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome.
    Staudacher HM; Rossi M; Kaminski T; Dimidi E; Ralph FSE; Wilson B; Martin LD; Louis P; Lomer MCE; Irving PM; Whelan K
    Neurogastroenterol Motil; 2022 Apr; 34(4):e14241. PubMed ID: 34431172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.
    Ankersen DV; Weimers P; Bennedsen M; Haaber AB; Fjordside EL; Beber ME; Lieven C; Saboori S; Vad N; Rannem T; Marker D; Paridaens K; Frahm S; Jensen L; Rosager Hansen M; Burisch J; Munkholm P
    J Med Internet Res; 2021 Dec; 23(12):e30291. PubMed ID: 34904950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.
    Altomare A; Di Rosa C; Imperia E; Emerenziani S; Cicala M; Guarino MPL
    Nutrients; 2021 Apr; 13(5):. PubMed ID: 33946961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritable bowel syndrome and gut microbiota.
    Canakis A; Haroon M; Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2020 Feb; 27(1):28-35. PubMed ID: 31789724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.